Nano Drug Delivery Strategies for the Treatment of Cancers
eBook - ePub

Nano Drug Delivery Strategies for the Treatment of Cancers

  1. 374 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Nano Drug Delivery Strategies for the Treatment of Cancers

About this book

Nano Drug Delivery Strategies for the Treatment of Cancers discusses several current and promising approaches for the diagnosis and treatment of cancer by using the most recent developments in nanomedical technologies. The book presents introductory information about the biology of different types of cancer in order to provide the reader with knowledge on their specificities. In addition, it discusses various novel drug delivery systems, detailing their functionalities, expected outcomes and future developments in the field, focusing on brain, mouth and throat, breast, lung, liver, pancreas, stomach, colon, bool, skin and prostate cancers.The book is a valuable source for cancer researchers, oncologists, pharmacologists and nanotechnologists who are interested in novel drug delivery systems and devices for treatment of various types of cancer that take advantage of recent advances in this exciting field.- Discusses a wide range of promising approaches for the diagnosis and treatment of cancer using the latest advancement in cutting-edge nanomedical technologies- Provides foundational information on different types of cancer and their biology to help the reader choose the best nano drug delivery system for patients- Presents novel drug delivery systems based on nanoparticles, microparticles, liposomes, self-assembling Micelles and block copolymer micelles

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Nano Drug Delivery Strategies for the Treatment of Cancers by Awesh K. Yadav,Umesh Gupta,Rajeev Sharma in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.

Information

Chapter 1

Emergence of novel targeting systems and conventional therapies for effective cancer treatment

Laxmikant Gautam1, Anamika Jain1, Priya Shrivastava1, Sonal Vyas2 and Suresh P. Vyas1, 11Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, India, 22Bundelkhand Medical College, Sagar, India

Abstract

As per the World Health Organization report (2018), cancer is one of the deadliest diseases in the world. Approximately, the second highest mortality is caused due to cancer. The uncontrolled growth and metastasis of abnormal cells are known as cancer. Currently, for the interdict of the rapid production of cancer cells, surgery, chemo-, or radiotherapy has a major contribution, but these conventional therapies are associated with various drawbacks such as normal tissue damage, poor aqueous solubility of bioactive(s), lack of selectivity, multidrug resistance, low bioavailability, toxicity, and side effects. For these limitations, numerous polymer or lipid-based novel drug delivery systems, that is, nanoparticles, liposomes, polymeric nanoparticles, solid lipid nanoparticles, etc., are discussed here, which are site-specific, and deliver the drug in a controlled and targeted manner. This chapter includes different novel drug delivery systems that have shown effective results over conventional therapies.

Keywords

Cancer; surgery; radiotherapy; chemotherapy; novel delivery system

1.1 Introduction

The World Health Organization clearly state in its report of 2018 that cancer is the second leading cause of death in the world, and it is assumed that it would increase exponentially to reach 12 million deaths per year by 2030 (Siegel, Miller, & Jemal, 2019). In developing and developed countries, a major cause of death is cancer due to bad habits (smoking tobacco, etc.) (Saadat et al., 2015). For the treatment of cancer, the therapeutic approaches used include chemotherapy, radiation, and surgery. Most of the time, combination therapy is applied to get the desired outcome and avoid resistance during cancer therapy. In cancer treatment, extensive heterogeneity in terms of response to drugs and drug resistance of melanomas are major impediments. The overexpression of antiapoptotic proteins and the emanation of anticancer drugs from cancer cells result in chemoresistance (Dry, Yang, & Saez-Rodriguez, 2016; Gandhi, Tekade, & Chougule, 2014; Xu et al., 2016). Although significant attempts have been made by researchers in the development of effective cancer therapies such as radiation, chemotherapy, surgery, immunotherapy, novel targeted approaches, or combinations of these approaches (Jain et al., 2018), the survival rate still remains quite low because the causes of cancer are still unknown. The survival rate and prognosis of cancer patients can be improved by early diagnosis at the early stages of cancer so that timely and effective treatment can be extended (Gautam & Anamikajain, 2019). Hence there is an urgent need for the development of improved alternative diagnostics and therapeutic strategies and interventions. The aim of these analyses of causes is to explore effective therapeutic opportunities to improve and increase the normal life span of cancer patients. Some of the conventional treatment procedures are described here for the treatment of cancer:
  • Primary treatment: By using this treatment cancer cells are removed from the body or destroyed completely. In every type of cancer, overgrowth surgical removal is the most accepted method used in primary treatment. If patients are sensitive to the other types of treatments such as radiation therapy or chemotherapy then surgery remains a good option.
  • Neoadjuvant or adjuvant treatment: The aim of this therapy is to kill those cancer cells that remain after the primary treatment, which can grow as a skipped lesson. Lai et al. worked on cancer in which miRNA was used as an adjuvant to increase the efficacy of small molecular inhibitor oncogenes (Lai, Eberhardt, Schmitz, & Vera, 2019). In clinical practice, in order to make primary treatment accessible, neoadjuvant therapy is given; for example, Lynn et al. report that in HER2-positive early breast cancer, an adjuvant treatment is given, which consisted of pertuzumab in combination with trastuzumab and chemotherapy (Howie et al., 2019).
  • Palliative treatment: Palliative treatments may be given at any stage of cancer treatment, which may help to control or reduce the side effects of cancer treatments, including pain, shortness of breath, and toxicity (de Man et al., 2019).
The critical analysis of these methods suggests that treatment strategies are largely dependent on the stage and type of cancer. The analysis further suggests that some patients need single treatment, while in most cases, a combination of treatments is beneficial in the later stages of cancer as reported in patent no. US10301290B2 (Keilhack, Knutson, & Kuntz, 2019). Thus surgery, chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy, etc., or a combination of any of these may be used for the treatment of cancer. In the present scenario, novel drug delivery approaches are being invented, targeted at different molecular targets such as the nucleus, mitochondria, cytoplasm, or endoplasmic reticulum for the effective treatment of cancer (Haider, Tiwari, Vyas, & Soni, 2019).

1.2 Conventional therapies for the treatment of cancer

1.2.1 Role of surgery for cancer treatment

Surgery is a medical branch that constitutes one of the treatment methods of cancer and that surgically removes cancer with the help of instruments. Surgery can involve cutting, abrading, suturing, or the management of acute illnesses and injuries as extricated from slowly progressing and chronic diseases.

1.2.1.1 Types of surgery

There are different types of surgery as shown in Fig. 1.1 and described here:
  • Curative surgery: The removal of a tumor from the body is known as curative surgery; radiation may be used before and/or after this surgery. This type of treatment is often considered as a primary form of treatment. Parker et al. reported that through the use of curative surgery in rural Kenya, the survival rate of colorectal cancer patients increased (Parker et al., 2020). In another research work, Liu et al. showed the clinical significance of curative surgery in skin lymph node metastasis in pN1 gastric cancer patients, which resulted in increased survival times (Liu, Deng, et al., 2019).
  • Preventive surgery: Preventive surgery is used to remove tissue that does not contain cancer cells, but may subsequently develop into a malignant tumor. For example, ipsilateral and contralateral breast cancer...

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. List of contributors
  7. Preface
  8. Chapter 1. Emergence of novel targeting systems and conventional therapies for effective cancer treatment
  9. Chapter 2. Nanomedicine: future therapy for brain cancers
  10. Chapter 3. Nano drug delivery strategies for the treatment and diagnosis of oral and throat cancers
  11. Chapter 4. Nanoparticles and lung cancer
  12. Chapter 5. Nanoparticles and liver cancer
  13. Chapter 6. Nanoparticles and pancreas cancer
  14. Chapter 7. The role of nanoparticles in the treatment of gastric cancer
  15. Chapter 8. Nanoparticles and colon cancer
  16. Chapter 9. Treating blood cancer with nanotechnology: A paradigm shift
  17. Chapter 10. Nanoparticles and skin cancer
  18. Chapter 11. Nanoparticles and prostate cancer
  19. Chapter 12. Nanomedicine-based multidrug resistance reversal strategies in cancer therapy
  20. Index